BackMeridian Bioscience Overview

Meridian Bioscience Total Revenue

Revenue analysis for VIVO.

Quarterly Revenue

$56.90M
35.59% YoY

As of Dec 2022

Annual Revenue (TTM)

$301.58M
3.75% YoY

Trailing 12 months ending Dec 2022

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading